boston scientific corp (BSX:New York)
Transactions by BOSTON SCIENTIFIC CORP (BSX) in the last 6 months
Boston Scientific Corporation (NYSE:BSX) signed a definitive agreement to acquire Interventional division of Bayer HealthCare AG for approximately $420 million in cash on May 14, 2014. The deal is inclusive of fees for transitional services. The transaction includes AngioJet Thrombectomy System and Fetch 2 Aspiration Catheter, and JetStream Atherectomy System. Upon completion, Interventional division will become part of Boston Scientific Peripheral Interventions business. ...
Boston Scientific Corporation (NYSE:BSX) signed a definitive agreement to acquire remaining 72% stake in IoGyn, Inc. for $65 million in cash on May 6, 2014. Total consideration includes cash payment at closing to acquire the remaining 72% of IoGyn and repay outstanding debt. Boston Scientific will integrate the operations of the IoGyn business into its Urology and Women’s Health division. The transaction is expected to close within days. Boston Scientific expects the ...
|Becton Dickinson and Co||$117.53 USD||-0.11|
|Coloplast A/S||kr466.20 DKK||+0.90|
|Olympus Corp||¥3,695 JPY||+90.00|
|St Jude Medical Inc||$64.55 USD||+0.22|
|Terumo Corp||¥2,605 JPY||+10.00|
|View Industry Companies|